SCHEMBL7385071

SCHEMBL7385071

CC1(C)CCc2[nH]cc(C(=O)Nc3cccnc3)c2C1=O

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 1/20 0.59
ROCK1 Q13464 1/20 0.59
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
HPGD P15428 1/20 0.44
KMT2A Q03164 1/20 0.44
TSHR P16473 1/20 0.44
NAMPT P43490 7/20 0.44
HTT P42858 1/20 0.44
CYP11B2 P19099 3/20 0.44
PTPN11 Q06124 1/20 0.43
CYP11B1 P15538 1/20 0.43
HSD17B10 Q99714 2/20 0.42
LMNA P02545 1/20 0.42
HIF1A Q16665 1/20 0.42
POLB P06746 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7392079 0.87 ROCK2 (0.63) ROCK2ROCK1ALDH1A1KDM4EKMT2A
SCHEMBL7397319 0.87 ROCK2 (0.68) ROCK2ROCK1ALDH1A1KDM4EMEN1
SCHEMBL6770578 0.82 BUB1 (0.50) ALDH1A1KDM4EMEN1HPGDKMT2A
SCHEMBL7399573 0.82 ROCK2 (0.58) ROCK2ROCK1ALDH1A1KDM4EMEN1
SCHEMBL7398675 0.81 ROCK2 (0.64) ROCK2ROCK1ALDH1A1KDM4EMEN1
SCHEMBL7395661 0.81 ROCK2 (0.57) ROCK2ROCK1ALDH1A1KDM4EMEN1
SCHEMBL7369380 0.80 ROCK2 (0.63) ROCK2ROCK1ALDH1A1KDM4EMEN1
SCHEMBL8038852 0.80 ALDH1A1 (0.48) ALDH1A1KDM4EMEN1HPGDKMT2A
SCHEMBL7386449 0.80 ALDH1A1 (0.48) ALDH1A1KDM4EMEN1HPGDKMT2A
SCHEMBL7392498 0.80 ROCK2 (0.49) ROCK2ROCK1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6096887-A USEFUL IN THE DIAGNOSIS AND TREATMENT OF ANXIETY, SLEEP AND SEIZURE DISORDERS, OVERDOSE WITH BENZODIAZEPINE DRUGS AND FOR ENHANCEMENT OF MEMORY. NEUROGEN CORPORATION (US) 2000-08-01 US claimed
WO-1998002433-A1 CERTAIN FUSED PYRROLECARBOXAMIDES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1998-01-22 WO claimed
US-6096887-A USEFUL IN THE DIAGNOSIS AND TREATMENT OF ANXIETY, SLEEP AND SEIZURE DISORDERS, OVERDOSE WITH BENZODIAZEPINE DRUGS AND FOR ENHANCEMENT OF MEMORY. NEUROGEN CORPORATION (US) 2000-08-01 US disclosed
US-5723462-A SLEEP AND SEIZURE DISORDERS; COGNITION ACTIVATORS, ANXIOLYTIC AGENTS NEUROGEN CORPORATION (US) 1998-03-03 US disclosed
WO-1998002433-A1 CERTAIN FUSED PYRROLECARBOXAMIDES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1998-01-22 WO disclosed